Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington’s Disease
Crossref DOI link: https://doi.org/10.1007/978-1-4939-7825-0_25
Published Online: 2018-06-01
Published Print: 2018
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bagher, Amina M.
Laprairie, Robert B.
Kelly, Melanie E. M.
Denovan-Wright, Eileen M.
License valid from 2018-01-01